Status:
UNKNOWN
Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Pulsed Radiofrequency
Super Voltage Pulsed Radiofrequency
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the safety and efficacy of supervoltage pulsed radiofrequency glossopharyngeal nerve therapy versus standard pulsed radiofrequency in reduction of oropharyngeal ca...
Detailed Description
The glossopharyngeal nerve is the 9th cranial nerve. It has motor, sensory and parasympathetic function like trigeminal and facial nerves. It has its origin in the medulla oblongata and exits the skul...
Eligibility Criteria
Inclusion
- Age ≥ 18 and ≤ 70 Years.
- Both sexes
- American Society of Anesthesiologists (ASA) class II and III.
- Patients under pain management for oropharyngeal cancer (failed medical treatment or intolerance to the side effects of the drug).
- Visual analog scale (VAS) equal to or more than 6 cm in spite medical treatment.
Exclusion
- Patient refusal.
- Patients with local or systemic sepsis.
- Uncorrectable coagulopathy.
- Unstable cardiovascular disease.
- History of psychiatric and cognitive disorders.
- Patients allergic to medication used.7
- Unable to lie supine.
- Local anatomical distortion (either congenital, post-surgical or post-radiotherapy) making intervention difficult and hazardous.
- Elongated styloid process \> 25 mm.
- Age less than 18 year and more than 70 year.
Key Trial Info
Start Date :
November 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06121102
Start Date
November 8 2023
End Date
April 1 2024
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 11796